Diagnostic Medical Systems S.A. (EPA:ALDMS)
France · Delayed Price · Currency is EUR 1.085
+0.005 (0.46%)
Aug 3, 2026, 1:33 PM CET
EPA:ALDMS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 49.97 | 46.07 | 42.15 | 35.27 | 36.27 | |
Revenue Growth | 8.48% | 9.29% | 19.51% | -2.75% | 12.67% |
Cost of Revenue | 31.8 | 30.32 | 28.1 | 23.02 | 24.32 |
Gross Profit | 18.17 | 15.75 | 14.05 | 12.26 | 11.95 |
Selling, General & Admin | 16.41 | 15.75 | 13.91 | 11.87 | 12.14 |
Depreciation & Amortization Expenses | 2.36 | 2.57 | 2.34 | 2.14 | 1.93 |
Other Operating Expenses | -1.78 | -2.22 | 0.07 | 4.13 | 0.2 |
Total Operating Expenses | 16.99 | 16.1 | 16.32 | 18.13 | 14.28 |
Operating Income | 1.18 | -0.35 | -2.27 | -5.88 | -2.32 |
Interest Income | 0.38 | 0.68 | 0.19 | 0.57 | 0.41 |
Interest Expense | -1.44 | -2.95 | -7.75 | -1.34 | -0.68 |
Total Non-Operating Income (Expense) | -1.06 | -2.27 | -7.57 | -0.77 | -0.27 |
Pretax Income | 0.12 | -2.61 | -9.83 | -6.64 | -2.59 |
Provision for Income Taxes | -0.07 | -0.21 | -0 | -0.02 | 0 |
Net Income | 0.12 | -2.61 | -9.83 | -6.64 | -2.59 |
Minority Interest in Earnings | 0.22 | 0.06 | -0.07 | -2.15 | -0.85 |
Earnings From Discontinued Operations | - | - | 4.82 | -2.31 | -2.13 |
Net Income to Common | -0.17 | -2.88 | -4.95 | -6.82 | -3.88 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 25 | 20 | 17 | 17 | 16 |
Shares Outstanding (Diluted) | 25 | 23 | 20 | 20 | 16 |
Shares Change | 8.57% | 12.41% | - | 25.66% | - |
EPS (Basic) | -0.01 | -0.14 | -0.28 | -0.00 | -0.24 |
EPS (Diluted) | -0.01 | -0.14 | -0.28 | -0.00 | -0.24 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.42 | 0.03 | -4.37 | -4.23 | -6.96 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.10 | 0.00 | -0.22 | -0.21 | -0.43 |
Gross Margin | 36.36% | 34.20% | 33.33% | 34.75% | 32.96% |
Operating Margin | 2.36% | -0.75% | -5.38% | -16.66% | -6.40% |
Profit Margin | 0.24% | -5.67% | -23.33% | -18.82% | -7.15% |
FCF Margin | -4.84% | 0.07% | -10.36% | -12.00% | -19.20% |
EBITDA | 3.67 | -0.41 | 2.06 | -2.41 | 1.38 |
EBITDA Margin | 7.35% | -0.90% | 4.88% | -6.82% | 3.79% |
EBIT | 1.18 | -0.35 | -2.27 | -5.88 | -2.32 |
EBIT Margin | 2.36% | -0.75% | -5.38% | -16.66% | -6.40% |
Effective Tax Rate | -60.66% | 7.85% | 0.02% | 0.30% | 0.00% |